Cassandra Jenkins

Using etrasimod with opioids or antidepressants did not increase risk for serotonin syndrome-associated adverse events among patients with ulcerative colitis, according to a study published in United European Gastroenterology Journal.

The addition of simvastatin plus rifaximin to standard therapy did not improve outcomes among patients with decompensated cirrhosis who were at high risk for clinical complications, according to a study published in JAMA.

Adults with irritable bowel syndrome who followed an IgG-guided elimination diet were more likely to experience a reduction in abdominal pain than those on a sham elimination diet, according to a study published in Gastroenterology.

SAN DIEGO — OB/GYNs reported feeling more comfortable performing penicillin allergy delabeling among pregnant women compared with allergists, according to a presentation here.

Normothermic machine perfusion was linked to significant improvements in liver transplant clinical outcomes and reduced hospital resource use, especially among patients who received donation after circulatory death allografts, data show.

People who engage in moderate to vigorous physical activity may be less likely to develop dementia, stroke, anxiety, depression and sleep disorders compared with those with more sedentary behavior, according to preliminary study results.

The AHFIRM trial did not demonstrate a beneficial effect of larsucosterol on 90-day mortality or the need for liver transplant among patients with severe alcohol-associated hepatitis, or AH, according to a study published in NEJM Evidence.

Administration of Ginkgo biloba extract did not significantly improve IOP or other endpoints of interest among patients with glaucoma or healthy volunteers, according to a review published in PLoS One.

The American Society of Anesthesiologists released new guidance on the safe use of ketamine for nonanesthesia purposes, such as the treatment of mental health disorders, according to an organization press release.

Korean adults with stable myopic normal-tension glaucoma who had not received IOP-lowering treatment for at least 1 year were at increased risk for progression, according to a study published in Journal of Glaucoma.